Haoyue Nursing (605009): Improving profitability and rewarding shareholders with high dividends
Haoyue Nursing (605009): Independent brands continue to promote overseas markets and can be expected to grow
SDIC Securities released a research report on April 25 stating that it gave Haoyue Nursing (605009.SH) a purchase rating, and the target price was 58.20 yuan. The main reasons for the rating include: 1) sales of baby hygiene products are increasing steadi
Haoyue Nursing (605009): Release of production capacity, steady development of domestic and foreign markets, and continuous promotion of independent brand building
Tianfeng Securities released a research report on April 14 stating that it gave Haoyue Nursing (605009.SH) a purchase rating. The main reasons for the rating include: 1) the company released its 2023 report; 2) large Thai and cross-border customers are gr
Haoyue Nursing (605009): 23 years of steady performance, deepening domestic and foreign business layout
Cinda Securities released a research report on April 13 stating that it gave Haoyue Nursing (605009.SH) an increase in its holdings. The main reasons for the rating include: 1) Product revenue was affected by the reduction in raw material prices; own-bran
Haoyue Nursing (605009): Stable products from the main domestic business go overseas, and the dividend rate is attractive
Haoyue Nursing (605009): Steady increase in profitability, continuous promotion of independent brands
Haoyue Nursing (605009): 1H23 revenue increased steadily and profitability recovered significantly
Haoyue Nursing (605009) Investment Value Analysis Report: New Product Launch Plus Raw Material Costs Fall, Absorbent Hygiene Products ODM Leading Performance Is Expected to Continue to Improve
Haoyue Nursing (605009): 22Q4 performance exceeded expectations, baby pants business bucked the trend
Haoyue Nursing (605009) 2022 Annual Report and 2023 Quarterly Report Reviews: Building a Base Steadily Promotes Independent Brand Promotion to Accelerate
Haoyue Nursing (605009) 2022 Report and 2023 Quarterly Report Reviews: 2023Q1 Performance and New Product Launch Expectations Are Expected to Strengthen Growth Expectations
Haoyue Nursing (605009): Leading diaper manufacturer with steady revenue and profit release
Haoyue Nursing (605009): 23Q1 performance was beautiful, profitability rebounded from the bottom
Haoyue Nursing (605009): 2023Q1 revenue performance was good, profitability was restored Haoyue Nursing
Haoyue Nursing (605009): Q1 revenue increased rapidly and profitability improved as scheduled
Haoyue Nursing (605009): 2022 ended successfully, and 2023 is expected to enter a period of rapid growth
Haoyue Nursing (605009) Company Review: Beautiful 1Q Performance, New Product Iteration Drives ODM Leader's Growth
No Data